4C Medical Technologies is a medical device company that develops minimally invasive therapies for structural heart disease.
4C Medical Technologies has raised $175.0M in total funding. The most recent round was Series D. The last funding was announced in March 2025.
4C Medical Technologies's investors include Boston Scientific, MicroPort CardioFlow, Anges Quebec, Yonghua Capital, Fu Yuan Investment.
4C Medical Technologies is headquartered in Maple Grove, United States.
4C Medical Technologies is a medical device company that develops minimally invasive therapies for structural heart disease.
4C Medical Technologies is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"4C Medical Technologies — Funding & Investors." VCBacked, March 5, 2025, https://www.vcbacked.co/company/4c-medical-technologies. Accessed August 13, 2026.
VCBacked. (2025). 4C Medical Technologies — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/4c-medical-technologies
{{cite web |title=4C Medical Technologies — Funding & Investors |url=https://www.vcbacked.co/company/4c-medical-technologies |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated